Author name: comtex

Pyrophyte Acquisition Corp. II Announces Closing of Over-Allotment Option, Resulting in Total Gross Proceeds of $200.4 Million in Initial Public Offering

Pyrophyte Acquisition Corp. II Announces Closing of Over-Allotment Option, Resulting in Total Gross Proceeds of $200.4 Million in Initial Public Offering GlobeNewswire July 29, 2025 HOUSTON, TX, July 29, 2025 (GLOBE NEWSWIRE) — Pyrophyte Acquisition Corp. II (NYSE: PAII.U) (the “Company”) today announced that it has consummated the sale of an additional 2,541,150 units subject […]

FluidCloud Emerges from Stealth with $8.1 Million to Unlock the Cloud

FluidCloud Emerges from Stealth with $8.1 Million to Unlock the Cloud The first Cloud Cloning(TM) solution to free enterprises from vendor lock-in with intelligent, portable infrastructure across all cloud environments GlobeNewswire July 29, 2025 PLEASANTON, Calif., July 29, 2025 (GLOBE NEWSWIRE) — FluidCloud, the pioneer in portable cloud infrastructure, launched today with $8.1 million in

AgEagle Aerial Systems Announces First Sale of Drones in Thailand

AgEagle Aerial Systems Announces First Sale of Drones in Thailand GlobeNewswire July 29, 2025 First Sale in Southeast Asia lays foundation for manufacturer's presence in region WICHITA, Kan., July 29, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to announce the

Volato Enters $320 Billion Critical Minerals Marketi with Execution of Definitive Agreement to Acquire M2i Global

Volato Enters $320 Billion Critical Minerals Marketi with Execution of Definitive Agreement to Acquire M2i Global GlobeNewswire July 29, 2025 Proposed Business Combination Will Create a Public Company that Aligns with U.S. Mineral Independence Strategy Atlanta, GA and Reno, NV, July 29, 2025 (GLOBE NEWSWIRE) — Volato Group, Inc. (“Volato”) (NYSE American: SOAR), a technology-driven

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP(TM) for Symptomatic Disc Degeneration

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP(TM) for Symptomatic Disc Degeneration Data readout expected in Q1 2026 GlobeNewswire July 29, 2025 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in

Sysco Reports Fourth Quarter and Full Year 2025 Results; Introduces FY26 Guidance

Sysco Reports Fourth Quarter and Full Year 2025 Results; Introduces FY26 Guidance GlobeNewswire July 29, 2025 HOUSTON, July 29, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for its 13-week fourth fiscal quarter and its fiscal year ended June 28, 2025. Key financial results for the fourth

SharpLink’s ETH Holdings Climb to 438,190 as of July 27, 2025; Raised $279.2 Million in ATM Net Proceeds For Week of July 21-25, 2025

SharpLink's ETH Holdings Climb to 438,190 as of July 27, 2025; Raised $279.2 Million in ATM Net Proceeds For Week of July 21-25, 2025 GlobeNewswire July 29, 2025 Total Staking Rewards Increase to 722 ETH As of July 27, 2025 MINNEAPOLIS, MN, July 29, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or

SunPower To Attend Canaccord’s Annual Growth Conference August 12th in Boston

SunPower To Attend Canaccord's Annual Growth Conference August 12th in Boston GlobeNewswire July 29, 2025 OREM, Utah, July 29, 2025 (GLOBE NEWSWIRE) — SunPower (aka Complete Solaria, Inc.) (“SunPower” or the “Company”) (Nasdaq: SPWR), a solar technology, services, and installation company, today announced the Company will attend the Canaccord Genuity 45th Annual Growth Conference, on

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301 PDUFA Fee Waiver comes Days before Planned Submission of New Drug Application GlobeNewswire July 29, 2025 KANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed

Franklin Electric Reports Second Quarter 2025 Results

Franklin Electric Reports Second Quarter 2025 Results GlobeNewswire July 29, 2025 Second Quarter 2025 Highlights Consolidated net sales of $587.4 million, an increase of 8% to the prior year Net sales increased across all three segments; 8% in Water Systems, 6% in Energy Systems, and 5% in Distribution Operating income was $88.1 million, an increase

Scroll to Top